HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evaluation of cisplatin in combination with a biologic response modifier in a murine mammary carcinoma model.

Abstract
The purpose of this study was to determine the efficacy of intracavitary cisplatin against local regrowth and metastasis after resection of a murine mammary carcinoma and the ability of a biologic response modifier (Virulizin) to enhance chemotherapy. C3H-HeJ mice were injected with Gollin-B tumor cells. Once growth reached 8 mm, tumors underwent marginal resection and the mice were assigned randomly to intraperitoneal (i.p.) cisplatin, Virulizin, a controlled release cisplatin-impregnated sponge (OPLA-Pt), a combination of treatments or no treatment and were evaluated for local regrowth, metastasis, and toxicity at 14 or 60 days after surgery. A possible beneficial interaction was seen between OPLA-Pt and Virulizin at 14 days. All cisplatin groups had significant advantages over controls in all variables measured with OPLA-Pt displaying significant advantages over i.p. cisplatin in local recurrence rate, tumor score, survival time, and delay in regrowth at 60 days. No toxicity related to either cisplatin or Virulizin was observed.
AuthorsEmanuela Morello, William S Dernell, Charles A Kuntz, Susan M LaRue, Mary Lafferty, Ann Nelson, John H Brekke, Craig H Mallinckrodt, Stephen J Withrow, Mark C Manning
JournalCancer investigation (Cancer Invest) Vol. 20 Issue 4 Pg. 480-9 ( 2002) ISSN: 0735-7907 [Print] England
PMID12094543 (Publication Type: Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Adjuvants, Immunologic
  • Antineoplastic Agents
  • Delayed-Action Preparations
  • Immunologic Factors
  • Polyesters
  • Polymers
  • Tissue Extracts
  • virulizin
  • Lactic Acid
  • poly(lactide)
  • Cisplatin
Topics
  • Adenocarcinoma (drug therapy, mortality, pathology)
  • Adjuvants, Immunologic (therapeutic use)
  • Animals
  • Antineoplastic Agents (therapeutic use)
  • Bile
  • Cisplatin (therapeutic use)
  • Delayed-Action Preparations
  • Drug Therapy, Combination
  • Female
  • Immunologic Factors (therapeutic use)
  • Injections, Intraperitoneal
  • Lactic Acid
  • Mammary Neoplasms, Experimental (drug therapy, mortality, pathology)
  • Mice
  • Mice, Inbred C3H
  • Neoplasm Recurrence, Local (drug therapy, pathology)
  • Polyesters
  • Polymers
  • Survival Rate
  • Tissue Extracts

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: